سرمایه گذاری البرز(هلدینگ
والبر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 3,700 0.82
Close Price: 3,640
Income Statement
AGM
Interim
2026/06/29 Fiscal Year 2026/03/2012 Month | 2025/05/29 Fiscal Year 2025/03/2012 Month | 2024/06/26 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Total Revenues | 4.667 Trillion | 2.955 Trillion | 7.455 Trillion | |
Gross Profit | 4.667 Trillion | 2.955 Trillion | 7.455 Trillion | |
General & Administrative Expenses | 524.038 Billion | 405.329 Billion | 297.252 Billion | |
Operating Profit (Loss) | 4.143 Trillion | 2.55 Trillion | 7.158 Trillion | |
Profit Before Tax | 7.815 Trillion | 13.418 Trillion | 13.796 Trillion | |
Tax | 42.889 Billion | 12.484 Billion | 66.745 Billion | |
Net Profit (Loss) After Tax | 7.772 Trillion | 13.405 Trillion | 13.729 Trillion | |
Retained Earnings at Beginning of Period | 12.79 Trillion | 11.594 Trillion | 10.044 Trillion | |
Approved Dividends — Prior Year AGM | -2.143 Trillion | -5.4 Trillion | -7.155 Trillion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | - | -6.81 Trillion | -5.047 Trillion | |
Transfer from Other Equity Items | -90.052 Billion | - | 23.391 Billion | |
Allocable Profit | 18.329 Trillion | 12.79 Trillion | 11.594 Trillion | |
Legal Reserve | 388.62 Billion | - | - | |
Other Reserves | 3.028 Trillion | - | - | |
Approved Dividends — Current Year | 1.147 Trillion | 2.143 Trillion | 5.4 Trillion | |
Retained Earnings at End of Period | 13.765 Trillion | 10.646 Trillion | 6.194 Trillion | |
سود حاصل از سرمایه گذاریها | 3.534 Trillion | - | - | |
سود حاصل از فروش سرمایه گذاریها | 1.132 Trillion | - | - | |
درآمد سود سپردههای بانکی | 946 Million | - | - | |
سود حاصل از سایر فعالیتها | - | 2.955 Trillion | 7.455 Trillion |